Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant

Blood(2022)

引用 0|浏览11
暂无评分
摘要
Introduction: The safety and efficacy of mRNA vaccines against SARS CoV 2 have proven widely among all age groups but not well studied among cancer patients who received Autologous Stem Cell Transplant (ASCT).
更多
查看译文
关键词
multiple myeloma patients,immunogenicity,stem cell transplant,vaccine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要